Pyridine

Pyridine

SCHEMBL6096884

CC(=O)OC(C)=O.ClCCl.c1ccncc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.39
NAPRT Q6XQN6 2/20 0.39
HSD17B10 Q99714 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
PLOD2 O00469 1/20 0.31
PLOD3 O60568 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
PLOD1 Q02809 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP19A1 P11511 1/20 0.31
PDE4D Q08499 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL30127 0.91 ALDH1A1 (0.53) ALDH1A1TSHRTDP1NAPRTHSD17B10
Pyridine SCHEMBL7939106 0.91 ALDH1A1 (0.53) ALDH1A1TSHRTDP1NAPRTHSD17B10
Pyridine SCHEMBL28342244 0.91 ALDH1A1 (0.53) ALDH1A1TSHRTDP1NAPRTHSD17B10
Benzene SCHEMBL3700434 0.91 ALDH1A1 (0.53) ALDH1A1TSHRTDP1NAPRTHSD17B10
Pyridine SCHEMBL3755683 0.91 ALDH1A1 (0.53) ALDH1A1TSHRTDP1NAPRTHSD17B10
Pyridine SCHEMBL27529683 0.86 ALDH1A1 (0.48) ALDH1A1TSHRTDP1NAPRTHSD17B10
Pyridine SCHEMBL28163753 0.83 TSHR (0.40) ALDH1A1TSHRTDP1NAPRTHSD17B10
Pyridine SCHEMBL10666474 0.81 ALDH1A1 (0.42) ALDH1A1TSHRTDP1NAPRTHSD17B10
Methylene Chloride SCHEMBL1594385 0.81 ALDH1A1 (0.67) ALDH1A1TSHRTDP1HSD17B10
Pyridine SCHEMBL1095589 0.81 NAPRT (0.60) ALDH1A1TSHRTDP1NAPRTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7002020-B1 Oxazolidinone combinatorial libraries, compositions and methods of preparation PHARMACIA & UPJOHN COMPANY (US) 2006-02-21 US disclosed
US-20050004174-A1 Antibacterial agents GORDEEV MIKHAIL F (US) 2005-01-06 US disclosed
US-6562844-B2 Attaching an olefin to a solid support; oxidizing the olefin to provide an epoxide functionality; opening the epoxide with an amine to form an amino alcohol; cyclizing the amino alcohol using a phosgene equivalent PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed
US-6531470-B1 Antimicrobial compounds PHARMACIA & UPJOHN COMPANY 2003-03-11 US disclosed
US-20020183371-A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation GORDEEV MIKHAIL F (US) 2002-12-05 US disclosed
US-6239152-B1 Oxazolidinone combinatorial libraries, compositions and methods of preparation PHARMACIA & UPJOHN COMPANY 2001-05-29 US disclosed
CN-1288462-A Oxazolidinone combinatorial libraries, compositions and method of prepn. UPJOHN CO (US) 2001-03-21 CN disclosed
EP-1049682-A1 OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION Versicor, Inc. (US) 2000-11-08 EP disclosed
WO-1999037630-A1 OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION VERSICOR, INC. (US) 1999-07-29 WO disclosed
EP-0570507-A4 ANTI-AGGREGATORY PEPTIDES CONTAINING AN AROMATIC ESTER OR AMIDE SMITHKLINE BEECHAM CORP (US) 1994-09-21 EP disclosed
EP-0570507-A1 ANTI-AGGREGATORY PEPTIDES CONTAINING AN AROMATIC ESTER OR AMIDE SMITHKLINE BEECHAM CORPORATION (US) 1993-11-24 EP disclosed
WO-1992013552-A1 ANTI-AGGREGATORY PEPTIDES CONTAINING AN AROMATIC ESTER OR AMIDE SMITHKLINE BEECHAM CORPORATION (US) 1992-08-20 WO disclosed
US-4474765-A Biologically active peptides FARMITALIA CARLO ERBA S.P.A. (IT) 1984-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183371-A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation PAICS, CDK4, OXA1L ALDH1A1 1371/4885TSHR 4600/4885TDP1 1808/4885
US-20050004174-A1 Antibacterial agents PAICS, OXA1L, PNKP ALDH1A1 1632/4885TSHR 4716/4885TDP1 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.